Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
Titel:
Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
Auteur:
Heim, Catrin Hartig, Leonie Weinelt, Nadine Moser, Laura M. Salzmann-Manrique, Emilia Merker, Michael Wels, Winfried S. Tonn, Torsten Bader, Peter Klusmann, Jan-Henning van Wijk, Sjoerd J.L. Rettinger, Eva